Search hospitals > Michigan > Grand Rapids
START Midwest
Claim this profileGrand Rapids, Michigan 49546
Global Leader in Solid Tumors
Global Leader in Tumors
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Colorectal Cancer
113 reported clinical trials
6 medical researchers
Summary
START Midwest is a medical facility located in Grand Rapids, Michigan. This center is recognized for care of Solid Tumors, Tumors, Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. START Midwest is involved with conducting 113 clinical trials across 148 conditions. There are 6 research doctors associated with this hospital, such as Nehal Lakhani, MD, Manish Sharma, MD, Katie Robinson, MD, and Sreenivasa Chandana, M.D., Ph.D..Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
2Tumors
Global LeaderStage IV
Stage III
KRAS positive
Top PIs
Nehal Lakhani, MDSTART Midwest4 years of reported clinical research
Expert in Tumors
Studies Solid Tumors
23 reported clinical trials
28 drugs studied
Manish Sharma, MDSTART Midwest5 years of reported clinical research
Studies Solid Tumors
Studies Cancer
15 reported clinical trials
27 drugs studied
Katie Robinson, MDSouth Texas Accelerated Research Therapeutics Midwest4 years of reported clinical research
Studies Breast Cancer
Studies Colorectal Cancer
6 reported clinical trials
9 drugs studied
Sreenivasa Chandana, M.D., Ph.D.START Midwest4 years of reported clinical research
Studies Adenocarcinoma
Studies Biliary Tract Cancer
6 reported clinical trials
21 drugs studied
Clinical Trials running at START Midwest
Solid Tumors
Tumors
Breast Cancer
Non-Small Cell Lung Cancer
Cancer
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Endometrial Cancer
Prostate Cancer
Zotatifin
for Solid Tumors
This trial is testing a new drug called Zotatifin for patients with advanced cancers that haven't improved with standard treatments. The drug works by stopping cancer cells from making essential proteins, which may slow or stop the cancer.
Recruiting3 awards Phase 1 & 221 criteria
AU-007
for Advanced Cancer
This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be administered either as a monotherapy, or in combination with a single loading dose of aldesleukin, or with both AU-007 and aldesleukin given every 2 weeks (Q2w)
Recruiting1 award Phase 1 & 28 criteria
MRTX1133
for Solid Cancers
A Phase 1/2 study of MRTX1133 in solid tumors harboring a KRAS G12D mutation.
Recruiting1 award Phase 1 & 27 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at START Midwest?
START Midwest is a medical facility located in Grand Rapids, Michigan. This center is recognized for care of Solid Tumors, Tumors, Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. START Midwest is involved with conducting 113 clinical trials across 148 conditions. There are 6 research doctors associated with this hospital, such as Nehal Lakhani, MD, Manish Sharma, MD, Katie Robinson, MD, and Sreenivasa Chandana, M.D., Ph.D..